EORTC presentations at ENCR Scientific Meeting in Baveno, Italy Oct 5-7 2016
5 Oct 2016
EORTC is conducting epidemiological outcome research, in partnership with population-based cancer registries in Europe, in part to evaluate real-world effectiveness of treatments tested in clinical research. As part of this, two studies will be presented as oral presentations at the European Network of Cancer Registries Scientific Meeting on October 7 under the theme ‘Cancer Registries and Clinical Data’.
The first study “Survival differences in Hodgkin lymphoma patients treated inside and outside clinical trials” will link data from six EORTC lymphoma trials and the Netherlands Cancer Registry (IKNL) to evaluate trial participation rate.
The same data is further linked with the Netherlands Patients Reported Outcome Cancer Registry (PROFILES) in the context of the second study: “Quality of life according to trial participation among Hodgkin lymphoma survivors.” Both studies are conducted in partnership with IKNL.
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023
